Cancer R&D 2027 | 12th International Conference on Cancer Research & Drug Development | October 13-15, 2027 | Houston, TX

Welcome to the 12th International Conference on Cancer Research and Development (Cancer R&D 2027), a prestigious three-day congress hosted by United Scientific Group (USG), a distinguished non-profit organization committed to the progression of cancer research.

Scheduled from October 13–15, 2027 in Houston, TX, this premier gathering unites global investigators, clinicians, and biotech innovators to cultivate knowledge, present unpublished breakthroughs, and foster cross-disciplinary collaborations that translate laboratory discoveries into life-saving therapies.

One of the memorable moments of Cancer R&D-2026 was the presentation of the Lifetime Achievement Award to Prof. Georg F. Weber, University of Cincinnati, Ohio, USA, in recognition of his distinguished contributions to cancer research, particularly his work on metastasis, integrin-CD44 signaling, and cancer-associated stress responses.

The award was presented by Prof. Kenneth Blum, President of United Scientific Group, together with Dr. Raghu Kalluri, the 2025 recipient of the Cancer R&D Lifetime Achievement Award.

Cancer R&D-2027 brings together diverse areas of oncology research, therapeutic innovation, and drug development through eight major scientific tracks. The program is designed to encourage interdisciplinary exchange and highlight advances spanning fundamental cancer biology to clinical applications. Further details on individual presentations, session schedules, and speakers will be announced as the program develops.

Having a great networking is inexpensive. It opens the doors for you and offers you a land of opportunity that might help you to spread your wings. Network face to face building a rapport with someone leading a solid connection in the research you are sailing. Cancer R&D 2027 brings that platform helping to create a foundational trust.